Patent ID: 11933783
Assignee: nan
Field: Measurement (Instruments)
Classification: CPC G  A | IPC A  G

Claim 2:
3. The method of claim 2, wherein the cancer therapeutic is selected from 5-Fluorouracil, 6-Mercaptopurine, 6-Thioguanine, Abemaciclib, Abiraterone Acetate, Acalabrutinib, Ado-Trastuzumab Emtansine, Afatinib Dimaleate, Aldesleukin, Alectinib, Alemtuzumab, Alpelisib, Amifostine, Aminolevulinic Acid Hydrochloride, Anastrozole, Apalutamide, Arsenic Trioxide, L-Asparaginase, Atezolizumab, Avelumab, Axitinib, Azacitidine, Belinostat, Bendamustine Hydrochloride, Bevacizumab, Bexarotene, Bicalutamide, Binimetinib, Bleomycin Sulfate, Blinatumomab, Bortezomib, Bosutinib, Brentuximab Vedotin, Brigatinib, Busulfan, Cabazitaxel, Cabozantinib-S-Malate, Calaspargase Pegol-mknl, Capecitabine, Caplacizumab-yhdp, Carboplatin, Carfilzomib, Carmustine, Carmustine Implant, Cemiplimab-rwlc, Ceritinib, Cetuximab, Chlorambucil, Cisplatin, Cladribine, Clofarabine, Cobimetinib, Copanlisib Hydrochloride, Corticosteroids, Crizotinib, Cyclophosphamide, Cytarabine, Dabrafenib Mesylate, Dacarbazine, Dacomitinib, Dactinomycin, Daratumumab, Darolutamide, Dasatinib, Daunorubicin Hydrochloride, Daunorubicin Hydrochloride and Cytarabine Liposome, Decitabine, Defibrotide Sodium, Degarelix, Denileukin Diftitox, Denosumab, Dexamethasone, Dexamethasone, Dexrazoxane Hydrochloride, Dinutuximab, Docetaxel, Doxorubicin Hydrochloride, Doxorubicin Hydrochloride Liposome, Durvalumab, Duvelisib, Elotuzumab, Eltrombopag Olamine, Emapalumab-lzsg, Enasidenib Mesylate, Encorafenib, Entrectinib, Enzalutamide, Epirubicin Hydrochloride, Erdafitinib, Eribulin Mesylate, Erlotinib Hydrochloride, Etoposide, Etoposide Phosphate, Everolimus, Exemestane, Fedratinib Hydrochloride, Fludarabine Phosphate, Flutamide, Fostamatinib Disodium, Fulvestrant, Gefitinib, Gemcitabine Hydrochloride, Gemtuzumab Ozogamicin, Gilteritinib Fumarate, Glasdegib Maleate, Glucarpidase, Goserelin Acetate, Hydroxyurea, Ibritumomab Tiuxetan, Ibrutinib, Idarubicin Hydrochloride, Idelalisib, Ifosfamide, Imatinib Mesylate, Imiquimod, Inotuzumab Ozogamicin, Interferon Alfa-2b, Recombinant, Iobenguane I 131, Ipilimumab, Irinotecan Hydrochloride, Irinotecan Hydrochloride Liposome, Ivosidenib, Ixabepilone, Ixazomib Citrate, Lanreotide Acetate, Lapatinib Ditosylate, Larotrectinib Sulfate, Lenalidomide, Lenvatinib Mesylate, Letrozole, Leuprolide Acetate, Lomustine, Lorlatinib, Mechlorethamine Hydrochloride, Megestrol Acetate, Melphalan, Methotrexate, Methylnaltrexone Bromide, Methylprednisolone, Midostaurin, Mitomycin C, Mitoxantrone Hydrochloride, Mogamulizumab-kpkc, Moxetumomab Pasudotox-tdfk, Necitumumab, Nelarabine, Neratinib Maleate, Netupitant and Palonosetron Hydrochloride, Nilotinib, Nilutamide, Niraparib Tosylate Monohydrate, Nivolumab, Obinutuzumab, Ofatumumab, Olaparib, Omacetaxine Mepesuccinate, Osimertinib Mesylate, Oxaliplatin, Paclitaxel, Paclitaxel Albumin-stabilized Nanoparticle Formulation, Palbociclib, Palifermin, Panitumumab, Panobinostat, Pazopanib Hydrochloride, Pegaspargase, Peginterferon Alfa-2b, Pembrolizumab, Pemetrexed Disodium, Pertuzumab, Polatuzumab Vedotin-piiq, Pomalidomide, Ponatinib Hydrochloride, Pralatrexate, Prednisone, Procarbazine Hydrochloride, Propranolol Hydrochloride, Raloxifene Hydrochloride, Ramucirumab, Ravulizumab-cwvz, Recombinant Interferon Alfa-2b, Regorafenib, Ribociclib, Rituximab, Rituximab and Hyaluronidase Human, Rolapitant Hydrochloride, Romidepsin, Romiplostim, Rucaparib Camsylate, Ruxolitinib Phosphate, Selinexor, Siltuximab, Sonidegib, Sorafenib Tosylate, Sunitinib Malate, Tagraxofusp-erzs, Talazoparib Tosylate, Tamoxifen Citrate, Temozolomide, Temsirolimus, Thalidomide, Thiotepa, Tocilizumab, Topotecan Hydrochloride, Toremifene, Trabectedin, Trametinib, Trastuzumab, Trastuzumab and Hyaluronidase-oysk, Trifluridine and Tipiracil Hydrochloride, Uridine Triacetate, Valrubicin, Vandetanib, Vemurafenib, Venetoclax, Vinblastine Sulfate, Vincristine Sulfate, Vincristine Sulfate Liposome, Vinorelbine Tartrate, Vismodegib, Vorinostat, Zanubrutinib, and Ziv-Aflibercept.